BERNARDO, MARIA ESTER
 Distribuzione geografica
Continente #
AS - Asia 3.733
EU - Europa 3.473
NA - Nord America 2.367
SA - Sud America 985
AF - Africa 82
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.654
Nazione #
US - Stati Uniti d'America 2.239
RU - Federazione Russa 1.988
SG - Singapore 1.429
CN - Cina 1.132
BR - Brasile 815
SE - Svezia 468
HK - Hong Kong 451
IT - Italia 362
VN - Vietnam 354
FR - Francia 172
DE - Germania 127
BD - Bangladesh 95
GB - Regno Unito 85
AR - Argentina 73
CA - Canada 67
IN - India 61
FI - Finlandia 58
NL - Olanda 58
AT - Austria 42
ID - Indonesia 41
MX - Messico 37
PL - Polonia 34
EC - Ecuador 30
IQ - Iraq 27
ZA - Sudafrica 26
TR - Turchia 19
UA - Ucraina 17
JP - Giappone 16
SA - Arabia Saudita 16
VE - Venezuela 16
CO - Colombia 15
UZ - Uzbekistan 14
ES - Italia 13
LT - Lituania 13
MA - Marocco 12
EG - Egitto 11
KE - Kenya 11
NP - Nepal 11
PY - Paraguay 11
IL - Israele 9
MY - Malesia 9
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
CL - Cile 7
CR - Costa Rica 7
DO - Repubblica Dominicana 7
IE - Irlanda 7
MD - Moldavia 7
PE - Perù 7
UY - Uruguay 7
JO - Giordania 6
PK - Pakistan 6
DZ - Algeria 5
IR - Iran 5
JM - Giamaica 5
AU - Australia 4
CZ - Repubblica Ceca 4
EU - Europa 4
TN - Tunisia 4
BE - Belgio 3
BO - Bolivia 3
LB - Libano 3
NZ - Nuova Zelanda 3
PH - Filippine 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CY - Cipro 2
ET - Etiopia 2
GR - Grecia 2
MT - Malta 2
NG - Nigeria 2
PT - Portogallo 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
EE - Estonia 1
FJ - Figi 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
NA - Namibia 1
NR - Nauru 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
TL - Timor Orientale 1
Totale 10.652
Città #
Singapore 534
Moscow 475
Hong Kong 451
Dallas 346
Ashburn 295
San Jose 266
Shanghai 240
Hefei 161
Beijing 149
Lauterbourg 139
Lawrence 138
Princeton 138
Ho Chi Minh City 125
New York 121
Milan 108
Hanoi 76
Los Angeles 72
São Paulo 66
Helsinki 37
Santa Clara 35
Boardman 33
Rome 30
Nuremberg 29
Orem 29
Dronten 26
Montreal 26
Rio de Janeiro 25
Warsaw 24
Council Bluffs 22
Guangzhou 22
Haiphong 22
London 22
Munich 21
Frankfurt am Main 20
Chennai 19
Curitiba 18
Houston 18
Chicago 17
Johannesburg 16
Toronto 16
Brooklyn 15
Tokyo 15
Brasília 14
Da Nang 14
Denver 14
Shenzhen 14
Tashkent 14
Atlanta 13
Guarulhos 13
Mexico City 13
Poplar 13
San Francisco 13
Turku 13
Vienna 13
Boston 12
Cesano Boscone 12
Phoenix 12
Stockholm 12
Guayaquil 11
Hangzhou 11
Hải Dương 11
Porto Alegre 11
Seattle 11
Belo Horizonte 10
Columbus 10
Monza 10
Nairobi 10
Salvador 10
Brescia 9
Las Vegas 9
Baghdad 8
Lappeenranta 8
Manchester 8
Mumbai 8
Recife 8
San Diego 8
The Dalles 8
Turin 8
Ankara 7
Boydton 7
Buffalo 7
Cumming 7
Ipatinga 7
Kuala Lumpur 7
Memphis 7
Quito 7
Reston 7
Sorocaba 7
Amman 6
Cairo 6
Campinas 6
Dhaka 6
Fortaleza 6
Itaquaquecetuba 6
Jakarta 6
Joinville 6
Montevideo 6
Phủ Lý 6
Pune 6
Querétaro 6
Totale 4.995
Nome #
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access 221
Rapamycin-Based GvHD Prophylaxis Is Effective in T-Cell Replete Unmanipulated Haploidentical Peripheral Stem Cell Transplantation for Advanced Haematological Malignancies: Results in 46 Patients 215
A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease 159
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency 156
Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy 139
Hematopoietic stem-and progenitor-cell gene therapy for hurler syndrome 137
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease 133
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome 127
A GLB1 transgene with enhanced therapeutic potential for the preclinical development of ex-vivo gene therapy to treat mucopolysaccharidosis type IVB 121
Access to gene therapy for rare diseases when commercialization is not fit for purpose 120
Peripheral blood stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series 119
An innovative platform approach for the development of ex-vivo gene therapies for the treatment of lysosomal storage diseases with skeletal involvement 118
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency 116
Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity 111
An early-senescence state in aged mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro-inflammatory program 109
Wiskott–Aldrich syndrome: Oral findings and microbiota in children and review of the literature 109
Assessment of human herpesvirus-6 infection in mesenchymal stromal cells ex vivo expanded for clinical use 107
Familial platelet disorder with propensity to acute myelogenous leukemia: Genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies 105
Up to 10.5 Years of Follow-Up in 17 Subjects Treated with Hematopoietic Stem and Progenitor Cell Lentiviral Gene Therapy for Wiskott-Aldrich Syndrome 104
Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study 104
Pioglitazone as a novel therapeutic approach in chronic granulomatous disease 100
Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the Art 100
A new enzyme-linked immunosorbent assay for a total anti-T lymphocyte globulin determination: Development, analytical validation, and clinical applications 98
Long-Term Effects of Atidarsagene Autotemcel for Metachromatic Leukodystrophy 97
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency 95
Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: Further insights in the search for a fatal calf serum substitute 95
Bone Marrow-Derived Mesenchymal Stromal Cell Intra-Fistular Injections Induce An Up-Regulation Of Foxp3+ Regulatory T-Cells In Patients With Crohn’s Disease 94
Allogeneic hematopoietic stem cell transplantation in thalassemia major: Results of a reduced-toxicity conditioning regimen based on the use of treosulfan 94
Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report 94
Adult autoimmune enteropathy treated with autologous bone marrow-derived mesenchymal stromal cells 93
Biological, functional and genetic characterization of bone marrow-derived mesenchymal stromal cells from pediatric patients affected by acute lymphoblastic leukemia 91
Evidence of Treatment Benefits in Patients with Mucopolysaccharidosis Type I-Hurler in Long-term Follow-up Using a New Magnetic Resonance Imaging Scoring System 89
Haematopoietic stem cell gene therapy in inborn errors of metabolism 88
Allogeneic hematopoietic stem cell transplantation may restore gluten tolerance in patients with celiac disease 88
A low thymic function is associated with leukemia relapse in children given T-cell-depleted HLA-haploidentical stem cell transplantation 88
Bone marrow-derived mesenchymal stromal cells (MSC) locally injected for refractory fistulizing Crohn’s disease modulate immunoglobulin production 87
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: Evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity 86
Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated BCGitis 85
Autologous bone marrow-derived mesenchymal stem cell infusion in crohn's disease patients with fistulas 84
Chromosome anomalies in bone marrow as primary cause of aplastic or hypoplastic conditions and peripheral cytopenia: Disorders due to secondary impairment of RUNX1 and MPL genes 84
The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy 82
Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs. 81
Cannabinoid receptor 2 as antiobesity target: Inflammation, fat storage, and browning modulation 81
Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation 80
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties 76
Cord blood transplantation in childhood 72
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia 70
Mesenchymal stromal cells: A novel treatment modality for tissue repair 70
Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells 70
Role of ex vivo Expanded Mesenchymal Stromal Cells in Determining Hematopoietic Stem Cell Transplantation Outcome 69
Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future 69
Familial myelodysplastic syndromes, monosomy 7/trisomy 8, and mutator effects 68
Safety and efficacy of mesenchymal stromal cell therapy in autoimmune disorders 68
Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis. 68
The human leucocyte antigen-G 14-basepair polymorphism correlates with graft-versus-host disease in unrelated bone marrow transplantation for thalassaemia 67
In-vivo T-regs generation by rapamycin-mycophenolate-ATG as a new platform for GvHD prophylaxis in T-cell repleted unmanipulated haploidentical peripheral stem cell transplantation: results in 59 patients 66
The Role of Conditioning in Hematopoietic Stem-Cell Gene Therapy 66
Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress 66
How I treat relapsed childhood acute lymphoblastic leukemia 64
MSCs in Pediatric Hematopoietic Stem Cell Transplantation (Chapter 26) 63
Ex vivo expansion of mesenchymal stromal cells 63
Generation of mesenchymal stromal cells in the presence of platelet lysate: A phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors 63
Current and Future Perspective in Hematopoietic Stem Progenitor Cell-gene Therapy for Inborn Errors of Metabolism 62
The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group 62
Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial 62
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major 62
γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes 62
Effects Of Bone Marrow-Derived Mesenchymal Stromal Cells Infused In Fistulas Of Patients With Perianal Crohn’s Disease On Serum Cytokine Pattern, Salivary Iga Production, And Circulating Lymphocyte Subsets 61
Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar) 60
Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantation 60
Mesenchymal stromal cells and chronic inflammatory bowel disease 60
Bone marrow-derived mesenchymal stromal cells locally injected for refractory fistulizing Crohn’s disease modulate serum immunoglobulins, secretory IgA, and antibody production 59
Mesenchymal Stromal Cells: Role in the BM Niche and in the Support of Hematopoietic Stem Cell Transplantation 59
Cord blood transplantation in children with haematological malignancies 58
Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia 58
Imbalanced TGFβ signalling and autophagy drive erythroid priming of hematopoietic stem cells in β-thalassemia 58
Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation 57
Gene therapy for mucopolysaccharidoses: In vivo and ex vivo approaches 10 Technology 1004 Medical Biotechnology 56
Human bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms 56
Transgenic expression of IL-10 by lentiviral vectors for increasing the anti-inflammatory efficacy of mesenchymal stromal cells 55
Bone Marrow-Derived Mesenchymal Stromal Cells Locally Injected Induce An Up-Regulation Of Both Circulating And Mucosal Foxp3+ Regulatory T-Cells In Patients With Perianal Crohn’s Disease 55
Multiparametric Whole Blood Dissection: A one-shot comprehensive picture of the human hematopoietic system 55
Low percentages of circulating CD8+/CD45RA+ human T lymphocytes expressing β7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation 55
Successful treatment of fistulizing crohn's disease with local infusions of autologous bone marrow-derived mesenchymal stem cells 54
Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources 54
Co-transplantation of ex-vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem cell transplantation 54
Successful Treatment With Ledipasvir/Sofosbuvir in an Infant With Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency With HCV Allowed Gene Therapy with Strimvelis 54
Neonatal gene therapy effectively prevents disease manifestations in a murine model of Mucopolysaccharidosis type I 53
Immunomodulatory properties of MSCs (Chapter 7) 53
Bone osteoblastic and mesenchymal stromal cells lack primarily tumoral features in multiple myeloma patients 53
MPSI Manifestations and Treatment Outcome: Skeletal Focus 51
Haematopoietic stem cell transplantation for patients with Thalassemia 51
Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I 51
Mesenchymal stromal cells: a novel and effective strategy for facilitating engraftment and accelerating hematopoietic recovery after transplantation? 51
Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation 51
Current practices for nutritional evaluation and care during the treatment of pediatric oncology patients: a survey among AIEOP centers 50
Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy 50
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study 50
Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I 50
Lentiviral gene therapy corrects platelet phenotype and function in Wiskott-Aldrich patients 49
Totale 8.113
Categoria #
all - tutte 67.573
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.573


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202285 0 0 0 43 4 7 4 3 15 1 4 4
2022/2023866 313 147 47 4 31 124 13 31 97 6 36 17
2023/2024435 20 23 30 47 36 45 84 32 3 12 31 72
2024/20252.409 317 48 99 36 67 154 253 209 449 325 228 224
2025/20266.960 472 583 479 1.072 491 198 571 489 1.801 348 239 217
Totale 10.861